Pulmonary surfactant is the material which, by lining the lung alveoli, prevents their collapse during expiration. The ability of this material to lower surface tensions, which would otherwise be generated by the presence of a fluidgas interface, in the alveolus has led to the designation 'surfactant'. Without surfactant alveoli cannot remain expanded and undergo collapse. Perhaps the most dramatic demonstration of the importance of lung surfactant concerns respiratory distress syndrome in newborn infants where the high surface tension of lung extracts is caused by a deficiency of surfactant. This deficiency is, in turn, caused by the immaturity of the alveolar epithelial type I1 cells responsible for surfactant synthesis and secretion.
Surfactant exists in at least four different morphological forms in vivo. It is present as lamellar bodies in the alveolar epithelial type I1 cells and exists as a film at the air-liquid interface, as common myelin or as tubular myelin in the alveolus. Although lamellar bodies and the two myelin forms can be isolated independently, most methods of surfactant isolation do not differentiate between the forms.
Lung lavage (with isotonic saline) is usually employed for the purification of extracellular surfactant. By using six to ten lavages a quantitative recovery of surfactant may be obtained although the bulk of the complex is removed by three to five washes. Free cells should be removed from the total lavage by centrifugation at low g forces and the pellet of cells resuspended and washed to remove any surfactant attached to their surface. In addition, tubular myelin can be easily sedimented, and great care has to be taken to keep the initial centrifugation to a minimum to avoid losses. Surfactant material can then be pelleted by centrifugation and further purified by density-gradient centrifugation. A variety of approaches have been used. Thus, surfactant has been isolated by flotation, by banding on continuous or discontinuous gradients and by pelleting on gradients composed of sodium chloride, sodium or potassium bromide, Ficoll, metrizamide, albumin and sucrose (c.f. Kikkawa & Smith, 1983; Sanders, 1982a) . As expected, there is considerable variation between the compositions of surfactants isolated by the various methods, although all preparations are rich in phosphatidylcholine and are surface-active on a Langmuir trough (c.f. King, 1974) . Two methods (Frosolono et al., 1970; King & Clements, 1972) have been widely employed. Both involve several gradient centrifugations with the latter's technique being particularly lengthy but yielding three fractions of precise isopycnic densities.
The centrifugation techniques recover most of surfactant phospholipids and can be used to isolate surfactant from tissue homogenates (i.e. intracellular as well as extracellular material). Indeed, the sodium bromide and sucrose gradient methods can be used to isolate the extracellular and intracellular pools separately (King & Clements, 1972; Pawlowski er al., 197 1). Sucrose-density-gradient centrifugation has also been used to isolate lamellar bodies from the type I1 cells (Gil & Reiss, 1973; Sanders et al., 1980) . Theisolated lamellar bodies have a morphological similarity to those of lung tissue, contain a phosphatidylcholine content close to that of isolated surfactants but are rather enriched in phosphatidylglycerol (1 2-14% phospholipids) and protein compared with extracellular surfactant (c.f. Sanders, 1982a) . A further source of lung surfactant is amniotic fluid. Since the fluid in the foetal lung is in direct communication with the amniotic fluid via the airway passages, then surfactant is expelled during the foetus's breathing movements. The amniotic fluid phosphatidylcholine (lecithin)/sphingomyelin ratio is often used as a test for lung maturation (c.f. Rooney, 1979) and surfactant can be purified from the fluid by appropriate methods (Frosolono & Roux, 1978) .
Typical isolated surfactant preparations contain less than 20% protein and, of the lipid, phosphatidylcholine is the major component, accounting for about 70-80% of the total lipid (Table 1 and c.f. Harwood et al., 1975; King, 1974; Rooney, 1979; Sanders, 1982,b) . Cholesterol is the main neutral lipid and phosphatidylethanolamine and phosphatidylglycerol are also significant components (Rooney, 1979; Sanders, 198%) . The relatively high content of phosphatidylglycerol in pulmonary surfactant is rather unusual because this phosphoglyceride is typically a major component of plant and microbial membranes. In animals it rarely represents more than a trace component (White, 1973) whereas in the lung it can represent up to 13% of the lamellar body phospholipids (Sanders et al., 1980) . Although it represents less than 10% of the surfacant lipid, phosphatidylglycerol may play a key role in facilitating the disruption of lamellar body surfactant extracellularly thus increasing the fluidity of dipalmitoylphosphatidylcholine (Sanders, 1982b) or by aiding the production of a surface-active monolayer through the involvement of non-bilayer structures with properties similar to hexagonal H-I1 phase (Yu et al., 1984) .
When the fatty acyl compositions of surfactant phosphatidylcholine is examined it is clear that palmitate is, by far, the predominate component (Table 2 ). In fact, when molecular species of this phosphoglyceride are separated then dipalmitoylphosphatidylcholine can represent up to 85% of the total lecithin. Dipalmitoylphosphatidylcholine (1975) and Sanders (1982a,b) . has a gel to liquid phase transition of 4loC and consequently it is clear that other lipids are required to allow normal spreading of surfactant at body temperature (c.f. Goerke, 1974 ). This problem is not helped by the fact that surfactant phosphatidylglycerol also contains large amounts of palmitate (Sanders, 1982b) . Early studies showed the presence of a number of proteins in the isolated surfactants. For example, Harwood et al. (1975) found nine to 20 proteins/polypeptides in surfactants isolated from different species and separated by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis under reducing conditions. There is no doubt that similarly complex pictures are still found in the most recent analysis ( e g Wright et al., 1984) but all workers seem to agree that three components are major (Sanders, 1982a) . These proteins haveM, values of about 1 1 000, 34 000 and 65 000. The latter is serum albumin while the other two are regarded as surfactant apoproteins. Metabolic studies in vivo have suggested that the smaller protein may be a metabolic product of the 34000-Mr protein (King et al., 1977) and studies with isolated type I1 cells show that the 34000-Mr protein is secreted with surfactant lipid whereas the 11 000-M, protein follows a different secretion pattern (King & Martin, 1980) . Of the various other proteins in isolated surfactant, secretory IgA may be important in enhancing the bactericidal capacity of alveolar macrophages (Juers et al., 1976) .
Several reviewers have stressed the extreme importance of assessing the physiological properties of surfactant and relating them to its function(s) in v i m . Methods are available to measure lung compliance (change in lung volume caused by a unit change in pressure) both statically and dynamically (c.f. Kotas, 1982) . Although these techniques are widely used, there are many problems in obtaining accurate measurements (Kotas, 1982) . Increases in surfactant levels during the last stages of gestation correlate with large increases in lung stability and distensibility. This correlation is easily explained when the surface properties of isolated surfactants are measured with a Wilhelmy surfacetension balance. Force/area relationships can be calculated from compression and expansion cycles and functional pulmonary surfactant is normally considered to be capable of generating a minimum surface tension on compression of lOdyne/cm or lower (c.f. Goerke, 1974). One major difficulty in these studies is the need to maintain a physiological (say 37°C) temperature during measurement (c.f. Kotas, 1982) . Although the balance film is not analogous in configuration to an alveolus, the behaviour of a surface film in a dynamic surface balance mimics surfactant behaviour in the lung (Clements, 1976 ). An alternative way of measuring low surface tension relies on examination of the behaviour of bubbles either through their persistence (Pattle, 1965) or during cyclic compression (Enhorning, 1977) .
It will be clear from the above discussion that the primary function of pulmonary surfactant is to increase lung compliance through lowering surface tension at the alveolar air-liquid interface. Thus it decreases the work of breathing and also lowers airway and alveolar opening pressures. In addition, surfactant helps keep alveoli relatively dry, enhances alveolar fluid and foreign particle clearance and may act as a cell-surface protector (Table 3) . Full discussion of these properties is not appropriate in this article but the reader is referred to various papers in Farrell (1 982) for further detail.
Clinical interest in pulmonary surfactant has concentrated on respiratory distress syndrome or hyaline mem- 3  81  6  3  5  2  Traces  5  73  6  3  10   1  2  2  80  1  2  6  6  3  2  63  6  3  15  11  Traces  4  6  2  Traces  2 86 The composition of pulmonary surfactant is remarkable in many respects: its high lipid content, its very high proportion of phosphatidylcholine (PC), especially dipalmitoylphosphatidylcholine (DPPC), and its relatively large amounts of phosphatidylglycerol (PG) (e.g. Harwood & Richards, 1985) . These lipids presumably have a major influence on surAbbreviations used: DPPC, dipalmitoylphosphatidylcholine; PC, phosphatidylcholine; PG, phosphatidylglycerol; PI, phosphatidylinositol.
Vol. 13 factant function. Other components such as phosphatidylinositol (PI), a specific protein, and not insignificant amounts of cholesterol and triacylglycerols also likely contribute to the overall functionality of surfactant. At various stages of the 'life cycle' of surfactant, this composition leads to organization of lipids into different structures which are essential to surfactant function.
As background it is useful to review the 'life cycle' of surfactant as shown diagrammatically in Fig. 1 . Material is synthesized in the endoplasmic reticulum of type I1 pneumocytes and packed (I, 11) in bilayers in secretory units called lamellar bodies. After secretion (111) of the material into the aqueous extracellular lining (hypophase) it undergoes transformation (IV) into an unusual structure called
